Syncom Formulations (India) Ltd.
•₹ 16.144.4%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Pharmacutical Drugs & Formulations: 97.5% • Trading of Comodities: 1.7% • Renting of Property: 0.8%
PROS
- Company has delivered good profit growth of 27.9% CAGR over last 5 years
- Company is almost debt free
- Latest quarter profit grew 56.3% YoY, showing strong momentum
- Company has delivered good sales growth of 17.6% CAGR over last 5 years
- Company comfortably covers its interest (77.1x coverage)
- Working capital cycle has improved - days down from 237 to 165
CONS
- A large part of profit comes from other income (26.6% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.30x)
- Recurring exceptional / one-off items are inflating headline profit
- Operating margins have contracted to 11.6% from 14.6%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SYNCOMF | 15.35 | 16.87 | 1442.90 | 0.00 | 24.85 | 57.72 | 125.53 | 7.38 | 18.77 | 20.88 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59 | 62 | 63 | 73 | 87 | 101 | 127 | 148 | 117 | 121 | 115 | 134 | 125 | |
| 53 | 56 | 57 | 64 | 76 | 90 | 112 | 131 | 101 | 103 | 93 | 113 | 101 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 4 | 4 | 3 | 1 | 4 | 4 | 7 | 6 | 5 | 5 | 14 | 8 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| 6 | 8 | 9 | 9 | 10 | 15 | 17 | 23 | 20 | 22 | 25 | 33 | 32 | |
| Tax % | 27.02% | 23.83% | 25.35% | 26.71% | 24.46% | 25.26% | 24.32% | 23.95% | 22.36% | 24.69% | 24.71% | 25.23% | 22.94% |
| Net Profit | 4 | 6 | 6 | 7 | 8 | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Equity Capital | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 | 94 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 59
- 53
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 1
- 6
- Tax %
- 27.02%
- Net Profit
- 4
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 62
- 56
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 1
- 8
- Tax %
- 23.83%
- Net Profit
- 6
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 63
- 57
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 1
- Depreciation
- 1
- 9
- Tax %
- 25.35%
- Net Profit
- 6
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 73
- 64
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 1
- Depreciation
- 1
- 9
- Tax %
- 26.71%
- Net Profit
- 7
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 87
- 76
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 1
- 10
- Tax %
- 24.46%
- Net Profit
- 8
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 101
- 90
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 1
- 15
- Tax %
- 25.26%
- Net Profit
- 11
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 127
- 112
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 0
- Depreciation
- 1
- 17
- Tax %
- 24.32%
- Net Profit
- 13
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 148
- 131
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 0
- Depreciation
- 1
- 23
- Tax %
- 23.95%
- Net Profit
- 18
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 117
- 101
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 0
- Depreciation
- 1
- 20
- Tax %
- 22.36%
- Net Profit
- 16
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 121
- 103
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 0
- Depreciation
- 1
- 22
- Tax %
- 24.69%
- Net Profit
- 17
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 115
- 93
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 0
- Depreciation
- 1
- 25
- Tax %
- 24.71%
- Net Profit
- 19
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 134
- 113
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 0
- Depreciation
- 2
- 33
- Tax %
- 25.23%
- Net Profit
- 25
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 125
- 101
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 2
- 32
- Tax %
- 22.94%
- Net Profit
- 25
- 0
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 94
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 184 | 185 | 159 | 187 | 206 | 245 | 220 | 225 | 258 | 463 | 495 | |
| 167 | 168 | 147 | 175 | 189 | 207 | 200 | 205 | 231 | 409 | 409 | |
| Operating Profit | 19 | 19 | 16 | 17 | 22 | 45 | 32 | 34 | 41 | 71 | — |
| OPM % | 11 | 11 | 10 | 9 | 11 | 18 | 15 | 15 | 16 | 15 | — |
| Other Income | 3 | 3 | 4 | 5 | 5 | 7 | 12 | 15 | 13 | 17 | 33 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 3 | 4 | 1 | 1 |
| Depreciation | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 7 |
| 16 | 16 | 12 | 13 | 17 | 41 | 26 | 27 | 32 | 65 | 112 | |
| Tax % | 36 | 33 | 28 | 13 | 18 | 28 | 24 | 24 | 26 | 24 | 24 |
| Net Profit | 10 | 11 | 9 | 11 | 14 | 29 | 20 | 20 | 24 | 49 | 85 |
| EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — |
| Dividend Payout % | 15 | 15 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | — |
Mar 2016
- 184
- 167
- Operating Profit
- 19
- OPM %
- 11
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 36
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2017
- 185
- 168
- Operating Profit
- 19
- OPM %
- 11
- Other Income
- 3
- Interest
- 0
- Depreciation
- 3
- 16
- Tax %
- 33
- Net Profit
- 11
- EPS
- 0
- Dividend Payout %
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2018
- 159
- 147
- Operating Profit
- 16
- OPM %
- 10
- Other Income
- 4
- Interest
- 0
- Depreciation
- 4
- 12
- Tax %
- 28
- Net Profit
- 9
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2019
- 187
- 175
- Operating Profit
- 17
- OPM %
- 9
- Other Income
- 5
- Interest
- 0
- Depreciation
- 4
- 13
- Tax %
- 13
- Net Profit
- 11
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2020
- 206
- 189
- Operating Profit
- 22
- OPM %
- 11
- Other Income
- 5
- Interest
- 1
- Depreciation
- 4
- 17
- Tax %
- 18
- Net Profit
- 14
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2021
- 245
- 207
- Operating Profit
- 45
- OPM %
- 18
- Other Income
- 7
- Interest
- 0
- Depreciation
- 4
- 41
- Tax %
- 28
- Net Profit
- 29
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2022
- 220
- 200
- Operating Profit
- 32
- OPM %
- 15
- Other Income
- 12
- Interest
- 2
- Depreciation
- 4
- 26
- Tax %
- 24
- Net Profit
- 20
- EPS
- 0
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2023
- 225
- 205
- Operating Profit
- 34
- OPM %
- 15
- Other Income
- 15
- Interest
- 3
- Depreciation
- 5
- 27
- Tax %
- 24
- Net Profit
- 20
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2024
- 258
- 231
- Operating Profit
- 41
- OPM %
- 16
- Other Income
- 13
- Interest
- 4
- Depreciation
- 5
- 32
- Tax %
- 26
- Net Profit
- 24
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2025
- 463
- 409
- Operating Profit
- 71
- OPM %
- 15
- Other Income
- 17
- Interest
- 1
- Depreciation
- 5
- 65
- Tax %
- 24
- Net Profit
- 49
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
TTM
- 495
- 409
- Operating Profit
- —
- OPM %
- —
- Other Income
- 33
- Interest
- 1
- Depreciation
- 7
- 112
- Tax %
- 24
- Net Profit
- 85
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 10%
- 5 Years:
- 18%
- 3 Years:
- 28%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 17%
- 5 Years:
- 28%
- 3 Years:
- 35%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 23%
- 1 Year:
- -11%
RETURN ON EQUITY
- 10 Years:
- 11%
- 5 Years:
- 12%
- 3 Years:
- 11%
- Last Year:
- 16%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 78 | 78 | 78 | 78 | 78 | 79 | 86 | 94 | 94 | 94 |
| 31 | 36 | 44 | 55 | 68 | 99 | 131 | 162 | 192 | 246 | |
| 6 | 12 | 12 | 9 | 2 | 62 | 58 | 83 | 72 | 4 | |
| Trade Payables | 47 | 32 | 22 | 21 | 20 | 29 | 14 | 20 | 14 | 43 |
| 19 | 20 | 17 | 14 | 16 | 22 | 19 | 17 | 21 | 25 | |
| Total Liabilities | 181 | 179 | 174 | 176 | 184 | 292 | 308 | 377 | 394 | 412 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 46 | 55 | 58 | 48 | 46 | 44 | 47 | 43 | 72 | 78 | |
| Capital Work in Progress | 5 | 0 | 1 | 0 | 0 | 0 | 6 | 26 | 0 | 0 |
| 23 | 1 | 2 | 2 | 1 | 11 | 43 | 64 | 66 | 93 | |
| 15 | 10 | 11 | 14 | 16 | 23 | 20 | 21 | 21 | 41 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93 | 107 | |
| Cash & Bank | 6 | 7 | 6 | 8 | 9 | 64 | 0 | 9 | 68 | 1 |
| 85 | 105 | 96 | 105 | 113 | 149 | 192 | 214 | 73 | 93 | |
| Total Assets | 181 | 179 | 174 | 176 | 184 | 292 | 308 | 377 | 394 | 412 |
| Total Debt | 6 | 12 | 13 | 9 | 2 | 62 | 58 | 83 | 72 | 4 |
| Net Working Capital | 26 | 30 | 39 | 46 | 58 | 93 | 62 | 68 | 168 | 209 |
| Contingent Liabilities | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Book Value per Share | 1.39 | 1.46 | 1.56 | 1.70 | 1.87 | 2.25 | 2.52 | 2.72 | 3.05 | 3.62 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 6 | 12 | 13 | 9 | 2 | 62 | 58 | 83 | 72 | 4 |
| Net Working Capital | 26 | 30 | 39 | 46 | 58 | 93 | 62 | 68 | 168 | 209 |
| Contingent Liabilities | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Book Value per Share | 1.39 | 1.46 | 1.56 | 1.70 | 1.87 | 2.25 | 2.52 | 2.72 | 3.05 | 3.62 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2016
- Equity Capital
- 78
- 31
- 6
- Trade Payables
- 47
- 19
- Total Liabilities
- 181
- 46
- Capital Work in Progress
- 5
- 23
- 15
- 0
- Cash & Bank
- 6
- 85
- Total Assets
- 181
- Total Debt
- 6
- Net Working Capital
- 26
- Contingent Liabilities
- 1
- Book Value per Share
- 1.39
- Face Value
- 1.00
- Total Debt
- 6
- Net Working Capital
- 26
- Contingent Liabilities
- 1
- Book Value per Share
- 1.39
- Face Value
- 1.00
Mar 2017
- Equity Capital
- 78
- 36
- 12
- Trade Payables
- 32
- 20
- Total Liabilities
- 179
- 55
- Capital Work in Progress
- 0
- 1
- 10
- 0
- Cash & Bank
- 7
- 105
- Total Assets
- 179
- Total Debt
- 12
- Net Working Capital
- 30
- Contingent Liabilities
- 3
- Book Value per Share
- 1.46
- Face Value
- 1.00
- Total Debt
- 12
- Net Working Capital
- 30
- Contingent Liabilities
- 3
- Book Value per Share
- 1.46
- Face Value
- 1.00
Mar 2018
- Equity Capital
- 78
- 44
- 12
- Trade Payables
- 22
- 17
- Total Liabilities
- 174
- 58
- Capital Work in Progress
- 1
- 2
- 11
- 0
- Cash & Bank
- 6
- 96
- Total Assets
- 174
- Total Debt
- 13
- Net Working Capital
- 39
- Contingent Liabilities
- 2
- Book Value per Share
- 1.56
- Face Value
- 1.00
- Total Debt
- 13
- Net Working Capital
- 39
- Contingent Liabilities
- 2
- Book Value per Share
- 1.56
- Face Value
- 1.00
Mar 2019
- Equity Capital
- 78
- 55
- 9
- Trade Payables
- 21
- 14
- Total Liabilities
- 176
- 48
- Capital Work in Progress
- 0
- 2
- 14
- 0
- Cash & Bank
- 8
- 105
- Total Assets
- 176
- Total Debt
- 9
- Net Working Capital
- 46
- Contingent Liabilities
- 2
- Book Value per Share
- 1.70
- Face Value
- 1.00
- Total Debt
- 9
- Net Working Capital
- 46
- Contingent Liabilities
- 2
- Book Value per Share
- 1.70
- Face Value
- 1.00
Mar 2020
- Equity Capital
- 78
- 68
- 2
- Trade Payables
- 20
- 16
- Total Liabilities
- 184
- 46
- Capital Work in Progress
- 0
- 1
- 16
- 0
- Cash & Bank
- 9
- 113
- Total Assets
- 184
- Total Debt
- 2
- Net Working Capital
- 58
- Contingent Liabilities
- 2
- Book Value per Share
- 1.87
- Face Value
- 1.00
- Total Debt
- 2
- Net Working Capital
- 58
- Contingent Liabilities
- 2
- Book Value per Share
- 1.87
- Face Value
- 1.00
Mar 2021
- Equity Capital
- 79
- 99
- 62
- Trade Payables
- 29
- 22
- Total Liabilities
- 292
- 44
- Capital Work in Progress
- 0
- 11
- 23
- 0
- Cash & Bank
- 64
- 149
- Total Assets
- 292
- Total Debt
- 62
- Net Working Capital
- 93
- Contingent Liabilities
- 1
- Book Value per Share
- 2.25
- Face Value
- 1.00
- Total Debt
- 62
- Net Working Capital
- 93
- Contingent Liabilities
- 1
- Book Value per Share
- 2.25
- Face Value
- 1.00
Mar 2022
- Equity Capital
- 86
- 131
- 58
- Trade Payables
- 14
- 19
- Total Liabilities
- 308
- 47
- Capital Work in Progress
- 6
- 43
- 20
- 0
- Cash & Bank
- 0
- 192
- Total Assets
- 308
- Total Debt
- 58
- Net Working Capital
- 62
- Contingent Liabilities
- 1
- Book Value per Share
- 2.52
- Face Value
- 1.00
- Total Debt
- 58
- Net Working Capital
- 62
- Contingent Liabilities
- 1
- Book Value per Share
- 2.52
- Face Value
- 1.00
Mar 2023
- Equity Capital
- 94
- 162
- 83
- Trade Payables
- 20
- 17
- Total Liabilities
- 377
- 43
- Capital Work in Progress
- 26
- 64
- 21
- 0
- Cash & Bank
- 9
- 214
- Total Assets
- 377
- Total Debt
- 83
- Net Working Capital
- 68
- Contingent Liabilities
- 1
- Book Value per Share
- 2.72
- Face Value
- 1.00
- Total Debt
- 83
- Net Working Capital
- 68
- Contingent Liabilities
- 1
- Book Value per Share
- 2.72
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 94
- 192
- 72
- Trade Payables
- 14
- 21
- Total Liabilities
- 394
- 72
- Capital Work in Progress
- 0
- 66
- 21
- 93
- Cash & Bank
- 68
- 73
- Total Assets
- 394
- Total Debt
- 72
- Net Working Capital
- 168
- Contingent Liabilities
- 1
- Book Value per Share
- 3.05
- Face Value
- 1.00
- Total Debt
- 72
- Net Working Capital
- 168
- Contingent Liabilities
- 1
- Book Value per Share
- 3.05
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 94
- 246
- 4
- Trade Payables
- 43
- 25
- Total Liabilities
- 412
- 78
- Capital Work in Progress
- 0
- 93
- 41
- 107
- Cash & Bank
- 1
- 93
- Total Assets
- 412
- Total Debt
- 4
- Net Working Capital
- 209
- Contingent Liabilities
- 1
- Book Value per Share
- 3.62
- Face Value
- 1.00
- Total Debt
- 4
- Net Working Capital
- 209
- Contingent Liabilities
- 1
- Book Value per Share
- 3.62
- Face Value
- 1.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 | 17 | -2 | 4 | 6 | -2 | 16 | 10 | -6 | 23 | |
| Cash from Investing | -23 | -8 | -2 | 2 | 2 | -75 | -27 | -45 | 84 | -18 |
| Cash from Financing | -2 | -2 | -2 | -0 | -7 | 72 | 8 | 35 | -15 | -68 |
| -1 | 6 | -6 | 7 | 1 | -5 | -2 | 1 | 63 | -63 | |
| Free Cash Flow | 17 | 12 | -8 | 4 | 4 | -5 | 5 | -10 | -14 | 13 |
| OCF / Net Profit | 2.32 | 1.59 | -0.19 | 0.39 | 0.41 | -0.07 | 0.83 | 0.52 | -0.25 | 0.48 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 30 | 8 | 1 | -1 | -20 | -11 |
| OCF / Net Profit | 2.32 | 1.59 | -0.19 | 0.39 | 0.41 | -0.07 | 0.83 | 0.52 | -0.25 | 0.48 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 30 | 8 | 1 | -1 | -20 | -11 |
Mar 2016
- 24
- Cash from Investing
- -23
- Cash from Financing
- -2
- -1
- Free Cash Flow
- 17
- OCF / Net Profit
- 2.32
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.32
- Cumulative 5-Year FCF
- 0
Mar 2017
- 17
- Cash from Investing
- -8
- Cash from Financing
- -2
- 6
- Free Cash Flow
- 12
- OCF / Net Profit
- 1.59
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.59
- Cumulative 5-Year FCF
- 0
Mar 2018
- -2
- Cash from Investing
- -2
- Cash from Financing
- -2
- -6
- Free Cash Flow
- -8
- OCF / Net Profit
- -0.19
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.19
- Cumulative 5-Year FCF
- 0
Mar 2019
- 4
- Cash from Investing
- 2
- Cash from Financing
- -0
- 7
- Free Cash Flow
- 4
- OCF / Net Profit
- 0.39
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.39
- Cumulative 5-Year FCF
- 0
Mar 2020
- 6
- Cash from Investing
- 2
- Cash from Financing
- -7
- 1
- Free Cash Flow
- 4
- OCF / Net Profit
- 0.41
- Cumulative 5-Year FCF
- 30
- OCF / Net Profit
- 0.41
- Cumulative 5-Year FCF
- 30
Mar 2021
- -2
- Cash from Investing
- -75
- Cash from Financing
- 72
- -5
- Free Cash Flow
- -5
- OCF / Net Profit
- -0.07
- Cumulative 5-Year FCF
- 8
- OCF / Net Profit
- -0.07
- Cumulative 5-Year FCF
- 8
Mar 2022
- 16
- Cash from Investing
- -27
- Cash from Financing
- 8
- -2
- Free Cash Flow
- 5
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 1
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 1
Mar 2023
- 10
- Cash from Investing
- -45
- Cash from Financing
- 35
- 1
- Free Cash Flow
- -10
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- -1
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- -1
Mar 2024
- -6
- Cash from Investing
- 84
- Cash from Financing
- -15
- 63
- Free Cash Flow
- -14
- OCF / Net Profit
- -0.25
- Cumulative 5-Year FCF
- -20
- OCF / Net Profit
- -0.25
- Cumulative 5-Year FCF
- -20
Mar 2025
- 23
- Cash from Investing
- -18
- Cash from Financing
- -68
- -63
- Free Cash Flow
- 13
- OCF / Net Profit
- 0.48
- Cumulative 5-Year FCF
- -11
- OCF / Net Profit
- 0.48
- Cumulative 5-Year FCF
- -11
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 0.13 | 0.14 | 0.11 | 0.14 | 0.18 | 0.37 | 0.23 | 0.21 | 0.25 | 0.52 |
| Book Value (₹) | 1.39 | 1.46 | 1.56 | 1.70 | 1.87 | 2.25 | 2.52 | 2.72 | 3.05 | 3.62 |
| Dividend per Share (₹) | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 0.17 | 0.18 | 0.16 | 0.19 | 0.23 | 0.42 | 0.28 | 0.26 | 0.30 | 0.58 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 10.42% | 10.54% | 10.17% | 9.06% | 10.71% | 18.46% | 14.58% | 15.35% | 10.78% | 11.56% |
| Net Margin % | 5.58% | 5.76% | 5.45% | 5.94% | 6.94% | 11.92% | 9.01% | 8.93% | 9.14% | 10.56% |
| ROE % | 9.91% | 9.56% | 7.33% | 8.71% | 10.24% | 18.04% | 10.02% | 8.48% | 8.71% | 15.61% |
| ROCE % | 14.72% | 13.58% | 9.43% | 9.37% | 12.39% | 20.72% | 10.61% | 9.68% | 10.39% | 18.66% |
| 6.41% | 5.93% | 4.90% | 6.34% | 7.92% | 12.27% | 6.60% | 5.86% | 6.13% | 12.13% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 76 | 91 | 96 | 77 | 75 | 88 | 118 | 116 | 119 | 79 |
| Inventory Days | 26 | 25 | 24 | 24 | 26 | 29 | 35 | 33 | 30 | 25 |
| Payable Days | 115 | 141 | 123 | 74 | 64 | 75 | 74 | 62 | 54 | 39 |
| -13 | -25 | -3 | 28 | 37 | 42 | 79 | 87 | 94 | 65 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.05x | 0.11x | 0.10x | 0.07x | 0.01x | 0.35x | 0.27x | 0.32x | 0.25x | 0.01x |
| Interest Coverage (x) | 119.10x | 45.48x | 41.40x | 52.62x | 29.18x | 86.35x | 14.58x | 8.81x | 8.14x | 77.05x |
| 1.39x | 1.54x | 1.91x | 2.27x | 2.87x | 1.96x | 1.79x | 1.61x | 2.72x | 4.47x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 6.06% | 0.50% | -14.17% | 17.74% | 10.03% | 19.12% | -10.27% | 2.27% | 15.01% | 79.15% |
| Operating Profit Growth % | -4.21% | 0.77% | -17.16% | 4.83% | 30.08% | 105.25% | -29.12% | 7.70% | 18.73% | 72.62% |
| Net Profit Growth % | 6.14% | 2.86% | -18.82% | 28.25% | 28.52% | 104.67% | -32.16% | 1.42% | 17.70% | 106.88% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.71% | 106.88% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 44.49x | 31.64x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.67x | 4.55x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 25.75x | 21.92x |
Mar 2016
- EPS (₹)
- 0.13
- Book Value (₹)
- 1.39
- Dividend per Share (₹)
- 0.02
- Cash EPS (₹)
- 0.17
- Operating Margin %
- 10.42%
- Net Margin %
- 5.58%
- ROE %
- 9.91%
- ROCE %
- 14.72%
- 6.41%
- Debtor Days
- 76
- Inventory Days
- 26
- Payable Days
- 115
- -13
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 119.10x
- 1.39x
- Revenue Growth %
- 6.06%
- Operating Profit Growth %
- -4.21%
- Net Profit Growth %
- 6.14%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 0.14
- Book Value (₹)
- 1.46
- Dividend per Share (₹)
- 0.02
- Cash EPS (₹)
- 0.18
- Operating Margin %
- 10.54%
- Net Margin %
- 5.76%
- ROE %
- 9.56%
- ROCE %
- 13.58%
- 5.93%
- Debtor Days
- 91
- Inventory Days
- 25
- Payable Days
- 141
- -25
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 45.48x
- 1.54x
- Revenue Growth %
- 0.50%
- Operating Profit Growth %
- 0.77%
- Net Profit Growth %
- 2.86%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 0.11
- Book Value (₹)
- 1.56
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.16
- Operating Margin %
- 10.17%
- Net Margin %
- 5.45%
- ROE %
- 7.33%
- ROCE %
- 9.43%
- 4.90%
- Debtor Days
- 96
- Inventory Days
- 24
- Payable Days
- 123
- -3
- Debt to Equity (x)
- 0.10x
- Interest Coverage (x)
- 41.40x
- 1.91x
- Revenue Growth %
- -14.17%
- Operating Profit Growth %
- -17.16%
- Net Profit Growth %
- -18.82%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 0.14
- Book Value (₹)
- 1.70
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.19
- Operating Margin %
- 9.06%
- Net Margin %
- 5.94%
- ROE %
- 8.71%
- ROCE %
- 9.37%
- 6.34%
- Debtor Days
- 77
- Inventory Days
- 24
- Payable Days
- 74
- 28
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 52.62x
- 2.27x
- Revenue Growth %
- 17.74%
- Operating Profit Growth %
- 4.83%
- Net Profit Growth %
- 28.25%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 0.18
- Book Value (₹)
- 1.87
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.23
- Operating Margin %
- 10.71%
- Net Margin %
- 6.94%
- ROE %
- 10.24%
- ROCE %
- 12.39%
- 7.92%
- Debtor Days
- 75
- Inventory Days
- 26
- Payable Days
- 64
- 37
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 29.18x
- 2.87x
- Revenue Growth %
- 10.03%
- Operating Profit Growth %
- 30.08%
- Net Profit Growth %
- 28.52%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 0.37
- Book Value (₹)
- 2.25
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.42
- Operating Margin %
- 18.46%
- Net Margin %
- 11.92%
- ROE %
- 18.04%
- ROCE %
- 20.72%
- 12.27%
- Debtor Days
- 88
- Inventory Days
- 29
- Payable Days
- 75
- 42
- Debt to Equity (x)
- 0.35x
- Interest Coverage (x)
- 86.35x
- 1.96x
- Revenue Growth %
- 19.12%
- Operating Profit Growth %
- 105.25%
- Net Profit Growth %
- 104.67%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 0.23
- Book Value (₹)
- 2.52
- Dividend per Share (₹)
- 0.03
- Cash EPS (₹)
- 0.28
- Operating Margin %
- 14.58%
- Net Margin %
- 9.01%
- ROE %
- 10.02%
- ROCE %
- 10.61%
- 6.60%
- Debtor Days
- 118
- Inventory Days
- 35
- Payable Days
- 74
- 79
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 14.58x
- 1.79x
- Revenue Growth %
- -10.27%
- Operating Profit Growth %
- -29.12%
- Net Profit Growth %
- -32.16%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 0.21
- Book Value (₹)
- 2.72
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.26
- Operating Margin %
- 15.35%
- Net Margin %
- 8.93%
- ROE %
- 8.48%
- ROCE %
- 9.68%
- 5.86%
- Debtor Days
- 116
- Inventory Days
- 33
- Payable Days
- 62
- 87
- Debt to Equity (x)
- 0.32x
- Interest Coverage (x)
- 8.81x
- 1.61x
- Revenue Growth %
- 2.27%
- Operating Profit Growth %
- 7.70%
- Net Profit Growth %
- 1.42%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.25
- Book Value (₹)
- 3.05
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.30
- Operating Margin %
- 10.78%
- Net Margin %
- 9.14%
- ROE %
- 8.71%
- ROCE %
- 10.39%
- 6.13%
- Debtor Days
- 119
- Inventory Days
- 30
- Payable Days
- 54
- 94
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 8.14x
- 2.72x
- Revenue Growth %
- 15.01%
- Operating Profit Growth %
- 18.73%
- Net Profit Growth %
- 17.70%
- 17.71%
- P/E (x)
- 44.49x
- P/B (x)
- 3.67x
- Dividend Yield %
- 0.00%
- 25.75x
Mar 2025
- EPS (₹)
- 0.52
- Book Value (₹)
- 3.62
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.58
- Operating Margin %
- 11.56%
- Net Margin %
- 10.56%
- ROE %
- 15.61%
- ROCE %
- 18.66%
- 12.13%
- Debtor Days
- 79
- Inventory Days
- 25
- Payable Days
- 39
- 65
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 77.05x
- 4.47x
- Revenue Growth %
- 79.15%
- Operating Profit Growth %
- 72.62%
- Net Profit Growth %
- 106.88%
- 106.88%
- P/E (x)
- 31.64x
- P/B (x)
- 4.55x
- Dividend Yield %
- 0.00%
- 21.92x
Documents
Announcements
- General Updates
2026-08-13 - Syncom Formulations (India) Limited has informed the Exchange about General Updates
- Disclosure of material issue
2026-08-13 - Syncom Formulations (India) Limited has informed regarding Disclosure of material issue
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.